SOMAVERT

This brand name is authorized in Austria, Australia, Brazil, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Turkey, United Kingdom

Active ingredients

The drug SOMAVERT contains one active pharmaceutical ingredient (API):

1 Pegvisomant UNII N824AOU5XV - PEGVISOMANT

Pegvisomant is an analogue of human growth hormone that has been genetically modified to be a growth hormone receptor antagonist for the treatment of adult patients with acromegaly. Pegvisomant is highly selective for the GH receptor, and does not cross-react with other cytokine receptors, including prolactin. Read about Pegvisomant

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SOMAVERT Powder and solvent for solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H01AX01	Pegvisomant	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01A Anterior pituitary lobe hormones and analogues → H01AX Other anterior pituitary lobe hormones and analogues
Discover more medicines within H01AX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11166Q, 11167R, 11172B, 11173C, 11174D, 11177G, 11179J, 11181L
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 522720050085917, 522720050086017, 522720050086117, 522720050086217, 522720050086317, 522720050086417, 522720050086517, 522721100090307, 522721100090407
Country: CA	Health Products and Food Branch	Identifier(s): 02272199, 02272202, 02272210, 02448831, 02448858
Country: EE	Ravimiamet	Identifier(s): 1196995, 1197008, 1197019, 1197020, 1709771, 1709782, 1709793, 1709805
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 02240001, 02240002, 02240003, 102240010, 102240012
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 126868, 142410, 532072, 540527, 588227
Country: FR	Base de données publique des médicaments	Identifier(s): 66553998, 67096189, 69108170
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 324177, 324180, 75435, 75439, 75443, 78464
Country: IE	Health Products Regulatory Authority	Identifier(s): 88854, 88855, 88856, 88857
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6058, 6059, 6060, 8089, 8090, 8164, 8165, 8166
Country: IT	Agenzia del Farmaco	Identifier(s): 035726013, 035726025, 035726037, 035726049, 035726052, 035726064, 035726076, 035726088
Country: JP	医薬品医療機器総合機構	Identifier(s): 2499409D1022, 2499409D2029, 2499409D3025
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1030814, 1030815, 1030816, 1030817, 1081289, 1081290, 1081291, 1081292
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 129720, 129723, 129739, 70491, 70505, 70513
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100126643, 100126650, 100126666, 100388745, 100388751
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64864001, W64865001
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681308278746, 8681308278753, 8681308278760